29 online
 
Most Popular Choices
Share on Facebook 31 Printer Friendly Page More Sharing
Sci Tech   

An Unproven Vaccine Is Too Risky

Quicklink Submitted By   11 comments
Message Helen Carpenter
Become a Fan
  (6 fans)

This piece was reprinted by OpEd News with permission or license. It may not be reproduced in any form without permission or license from the source.

Opinion piece by Dr. Tim Lahey, an infectious-disease physician and vaccine researcher.  He writes:

 "Unproven vaccines have real risks. The 1976 swine flu vaccine was linked to a rare paralytic neurological illness called Guillain-Barré syndrome, arguably fueling vaccine mistrust that persists to this day. One novel H.I.V. trial was stopped early because certain vaccine recipients became more likely to be infected than placebo recipients. In trials of a vaccine against the syncytial respiratory virus, children who received the vaccine experienced enhanced disease that even lead to deaths. In each case, the immune response stimulated by the experimental vaccine was probably more harmful than helpful."

Read the rest of the story HERE:

At www.nytimes.com
Must Read 1   Supported 1   Valuable 1  
Rate It | View Ratings

Helen Carpenter Social Media Pages: Facebook page url on login Profile not filled in       Twitter page url on login Profile not filled in       Linkedin page url on login Profile not filled in       Instagram page url on login Profile not filled in


As a young girl dining nightly to TV images of GI's dragging their buddies out of the rice paddies of Vietnam, this engendered a certain notion that somehow the world should be a better place. (more...)
 
Related Topic(s): Illness; Vaccines, Add Tags
Go To Commenting
The views expressed herein are the sole responsibility of the author and do not necessarily reflect those of this website or its editors.
Writers Guidelines

 
Contact AuthorContact Author Contact EditorContact Editor Author PageView Authors' Articles
Support OpEdNews

OpEdNews depends upon can't survive without your help.

If you value this article and the work of OpEdNews, please either Donate or Purchase a premium membership.

STAY IN THE KNOW
If you've enjoyed this, sign up for our daily or weekly newsletter to get lots of great progressive content.
Daily Weekly     OpEd News Newsletter
Name
Email
   (Opens new browser window)
 

To View Comments or Join the Conversation:

Tell A Friend